772 (Lansoprazole Delayed-Release (Orally Disintegrating) 30 mg)
Pill with imprint 772 is White, Round and has been identified as Lansoprazole Delayed-Release (Orally Disintegrating) 30 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..
Lansoprazole is used in the treatment of barrett's esophagus; duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 772
Lansoprazole Delayed-Release (Orally Disintegrating)
- Imprint
- 772
- Strength
- 30 mg
- Color
- White
- Shape
- Round
- Availability
- Rx and/or OTC
- Drug Class
- Proton pump inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 70771-1133
Related Images for "772"
More about lansoprazole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- 118 Reviews
- Drug class: proton pump inhibitors
- FDA Alerts (4)
Consumer resources
- Patient Information
- Lansoprazole (Advanced Reading)
- Lansoprazole Orally Disintegrating Tablets
- Lansoprazole Delayed-Release Capsules
- Lansoprazole Suspension
- Other brands
- Prevacid, Prevacid SoluTab, Prevacid OTC
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.